Accelerate to discover

Back to filter

Related topics

Zebrafish heart imaging

Bruker Biospin

Nov 14, 2019

Today watch this interesting video interview with Anabela Bensimon-Brito, Department of Developmental Genetics, Max...

Advancing Alzheimer's disease rsearch with IncuCyte S3 for Neuroscience

Sartorius

Nov 12, 2019

IncuCyte S3 Live-Cell Analysis System for Neuroscience: enables real-time automated measurements of the dynamic changes...

Webinar recording: Analysis of extracellular vesicles by AMNIS imaging flow cytometer

Luminex

Nov 4, 2019

Although conventional flow cytometry is limited to measure small particles down to approximately 300 nm – 500 nm, an...

Targeted mitochondrial DNA extraction and enrichment using the SageHLS

Sage Science

Oct 31, 2019

Sage Science introduced a novel approach for enriching mitochondrial DNA for sequence analysis without PCR or gradient...

Nov 14, 2019

Join the webcast: Addressing cancer gene therapy efficacy with IncuCyte Live–Cell Imaging

Sartorius

Oct 29, 2019

During this webinar, Dr Pierre Cordelier will discuss the use of IncuCyte Live-Cell Imaging and Analysis, to track gene...

Oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer at a single low dose

Spectral Instruments Imaging

Oct 24, 2019

Pancreatic ductal adenocarcinoma (PDAC) has been increasing by 0.5% per year in the United States. This study describes...

New code dedicated to esophageal procedures with Confocal Laser Endomicroscopy

Mauna Kea Technologies

Oct 21, 2019

Announcement of the creation of a new specific procedural code to be added to the Common Classification of Medical...

Nov 14, 2019

Cytek Biosciences hits flow cytometry milestone: 40 color analysis from a single sample

Cytek Biosciences

Oct 17, 2019

Cytek Aurora turning aspirations into realizations: 40 Colors, One Tube. Until recently, developing fluorescence-based...

Show all topics (10)

Expression profiling of ribosome biogenesis factors in AML patients

Apr 20, 2017

Acute myeloid leukemia (AML) is a heterogeneous disease. Prognosis is mainly influenced by patient age at diagnosis and cytogenetic alterations, two of the main factors currently used in AML patient risk stratification. However, additional criteria are required to improve the current risk classification and better adapt patient care. In neoplastic cells, ribosome biogenesis is increased to sustain the high proliferation rate and ribosome composition is altered to modulate specific gene expression driving tumorigenesis. Here, we investigated the usage of ribosome biogenesis factors as clinical markers in adult patients with AML. We showed that nucleoli, the nucleus compartments where ribosome production takes place, are modified in AML by analyzing a panel of AML and healthy donor cells using immunofluorescence staining. Using four AML series, including the TCGA dataset, altogether representing a total of about 270 samples, we showed that not all factors involved in ribosome biogenesis have clinical values although ribosome biogenesis is increased in AML. Interestingly, we identified the regulator of ribosome production nucleolin (NCL) as over-expressed in AML blasts. Moreover, we found in two series that high NCL mRNA expression level was associated with a poor overall survival, particular in elderly patients. Multivariate analyses taking into account age and cytogenetic risk indicated that NCL expression in blast cells is an independent marker of reduced survival. Our study identifies NCL as a potential novel prognostic factor in AML. Altogether, our results suggest that the ribosome biogenesis pathway may be of interest as clinical markers in AML.

Read more

 

Scientific paper
Application

Get more info

Regina Fillerová

Field application specialist

Regina

Fillerová

+420 731 127 718

Send Message

Brand profile

Fluidigm

Fluidigm is a Molecular and Single Cell Biology company that creates microfluidic-based chips and instrumentation for Life-Science research.

Related products

A new standard for high-throughput real-time PCR, end-point PCR and digital PCR

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey